Suppr超能文献

金黄色葡萄球菌表面抗原-锰转运蛋白 MntC 的三维结构和生物物理特性。

Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC.

机构信息

Pfizer Vaccine Research, 401 North Middletown Road, Pearl River, NY 10965, USA.

出版信息

J Mol Biol. 2013 Sep 23;425(18):3429-45. doi: 10.1016/j.jmb.2013.06.033. Epub 2013 Jul 1.

Abstract

MntC is a metal-binding protein component of the Mn²⁺-specific mntABC transporter from the pathogen Staphylococcus aureus. The protein is expressed during the early stages of infection and was proven to be effective at reducing both S. aureus and Staphylococcus epidermidis infections in a murine animal model when used as a vaccine antigen. MntC is currently being tested in human clinical trials as a component of a multiantigen vaccine for the prevention of S. aureus infections. To better understand the biological function of MntC, we are providing structural and biophysical characterization of the protein in this work. The three-dimensional structure of the protein was solved by X-ray crystallography at 2.2Å resolution and suggests two potential metal binding modes, which may lead to reversible as well as irreversible metal binding. Precise Mn²⁺-binding affinity of the protein was determined from the isothermal titration calorimetry experiments using a competition approach. Differential scanning calorimetry experiments confirmed that divalent metals can indeed bind to MntC reversibly as well as irreversibly. Finally, Mn²⁺-induced structural and dynamics changes have been characterized using spectroscopic methods and deuterium-hydrogen exchange mass spectroscopy. Results of the experiments show that these changes are minimal and are largely restricted to the structural elements involved in metal coordination. Therefore, it is unlikely that antibody binding to this antigen will be affected by the occupancy of the metal-binding site by Mn²⁺.

摘要

MntC 是病原体金黄色葡萄球菌中 Mn²⁺特异性 mntABC 转运蛋白的金属结合蛋白成分。该蛋白在感染的早期阶段表达,当用作疫苗抗原时,已被证明可有效降低小鼠动物模型中的金黄色葡萄球菌和表皮葡萄球菌感染。MntC 目前正在作为多抗原疫苗的一部分进行人类临床试验,用于预防金黄色葡萄球菌感染。为了更好地了解 MntC 的生物学功能,我们在这项工作中提供了该蛋白的结构和生物物理特性。该蛋白的三维结构通过 X 射线晶体学以 2.2Å 的分辨率解决,并提出了两种潜在的金属结合模式,这可能导致可逆和不可逆的金属结合。通过使用竞争方法的等温滴定量热法实验确定了蛋白对 Mn²⁺的确切结合亲和力。差示扫描量热法实验证实,二价金属确实可以可逆和不可逆地与 MntC 结合。最后,使用光谱方法和氘-氢交换质谱法对 Mn²⁺诱导的结构和动力学变化进行了表征。实验结果表明,这些变化很小,并且主要限于涉及金属配位的结构元素。因此,抗体与该抗原的结合不太可能受到 Mn²⁺占据金属结合位点的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验